Arcturus Therapeutics Holdings Inc. (ARCT) Financials

ARCT Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 245.4 million 54.0 million
Dec. 31, 2025 271.1 million 57.2 million
Sept. 30, 2025 282.3 million 57.8 million
June 30, 2025 309.3 million 78.2 million

ARCT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -19.4 million 4.3 million
Dec. 31, 2025 -16.4 million 6.8 million
Sept. 30, 2025 -17.3 million 5.7 million
June 30, 2025 -5.8 million 6.2 million

ARCT Net Income

No data available :(

ARCT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 211.4 million 19.7 million -
Dec. 31, 2025 230.9 million - 20.8 million
Sept. 30, 2025 180.4 million - 21.9 million
June 30, 2025 196.5 million - 27.0 million

ARCT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 28.4 million
Dec. 31, 2025 27.4 million
Sept. 30, 2025 27.2 million
June 30, 2025 27.1 million

ARCT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 20.9 million 8.8 million -658000
Dec. 31, 2025 137660 24.5 million 14.0 million -
Sept. 30, 2025 181000 23.3 million 10.4 million -
June 30, 2025 - 29.6 million 10.3 million -

ARCT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 610000 658000
Dec. 31, 2025 3.1 million 682000
Sept. 30, 2025 17.2 million 3.3 million
June 30, 2025 24.5 million -

ARCT Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ARCT

Price: $7.14

52 week price:
5.85
24.17

Payout Ratio Range:
-101.10%
-50.26%

Earnings Per Share: -2.83 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 359653

Ebitda: -2.9 million

Market Capitalization: 217.4 million

Links: